Product Name
alpha-Spectrin (SPTAN1), Monoclonal Antibody
Full Product Name
Purified anti-alpha-Spectrin (SPTAN1) Antibody
Product Synonym Names
Spectrin alpha chain non-erythrocytic 1; fodrin alpha chain
Product Gene Name
anti-SPTAN1 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P02549
Form/Format
Phosphate-buffered solution, pH 7.2.
Preparation
The antibody was purified by affinity chromatography.
Structure
SPTAN1 is a 285 kD cytoskeleton protein.
Preparation and Storage
Store lyophilized antibody at -20 degree C. After reconstitution, store at 4 degree C. May be sub-aliquoted and stored at -20 degree C to avoid multiple freeze thaw cycles.
Other Notes
Small volumes of anti-SPTAN1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-SPTAN1 antibody
The?spectrins?are a family of widely distributed?cytoskeletal?proteins which are involved in?actin?crosslinking. Spectrin alpha-chain heterodimerizes with tissue-specific beta-chains.?It is specifically expressed in nonerythrocytic cells. The protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in the gene are the cause of early infantile epileptic encephalopathy. Fodrin, which seems to be involved in secretion, interacts with calmodulin in a calcium-dependent manner and is thus a candidate for the calcium-dependent movement of the cytoskeleton at the membrane.
Applications Tested/Suitable for anti-SPTAN1 antibody
Western Blot (WB), ELISA (EIA)
Application Notes for anti-SPTAN1 antibody
Each lot of this antibody is quality control tested by Western blotting. To reconstitute, add 100 ul of ddH2O to the tube containing antibody and mix to dissolve. For Western blotting, the suggested dilution is 1:1000 after reconsitution. It is recommended that the reagent be titrated for optimal performance for each application.
NCBI/Uniprot data below describe general gene information for SPTAN1. It may not necessarily be applicable to this product.
NCBI Accession #
AAA60994.1
[Other Products]
UniProt Primary Accession #
P02549
[Other Products]
UniProt Secondary Accession #
Q15514; Q5VYL1; Q5VYL2; Q6LDY5[Other Products]
UniProt Related Accession #
P02549[Other Products]
Molecular Weight
279,674 Da
NCBI Official Full Name
alpha-spectrin
NCBI Official Synonym Full Names
spectrin, alpha, erythrocytic 1
NCBI Official Symbol
SPTA1??[Similar Products]
NCBI Official Synonym Symbols
EL2; HPP; HS3; SPH3; SPTA
??[Similar Products]
NCBI Protein Information
spectrin alpha chain, erythrocytic 1; alpha-I spectrin; elliptocytosis 2; erythroid alpha-spectrin; spectrin alpha chain, erythrocyte; spectrin, alpha, erythrocytic 1 (elliptocytosis 2)
UniProt Protein Name
Spectrin alpha chain, erythrocytic 1
UniProt Synonym Protein Names
Erythroid alpha-spectrin
UniProt Gene Name
SPTA1??[Similar Products]
UniProt Synonym Gene Names
SPTA??[Similar Products]
UniProt Entry Name
SPTA1_HUMAN
NCBI Summary for SPTAN1
Spectrin is an actin crosslinking and molecular scaffold protein that links the plasma membrane to the actin cytoskeleton, and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. It is a tetramer made up of alpha-beta dimers linked in a head-to-head arrangement. This gene is one member of a family of alpha-spectrin genes. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms weaker tetramer interactions than non-erythrocytic alpha spectrin, which may increase the plasma membrane elasticity and deformability of red blood cells. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis type 2, pyropoikilocytosis, and spherocytic hemolytic anemia. [provided by RefSeq, Jul 2008]
UniProt Comments for SPTAN1
SPTA1: Spectrin is the major constituent of the cytoskeletal network underlying the erythrocyte plasma membrane. It associates with band 4.1 and actin to form the cytoskeletal superstructure of the erythrocyte plasma membrane. Defects in SPTA1 are the cause of elliptocytosis type 2 (EL2). EL2 is a Rhesus-unlinked form of hereditary elliptocytosis, a genetically heterogeneous, autosomal dominant hematologic disorder. It is characterized by variable hemolytic anemia and elliptical or oval red cell shape. Defects in SPTA1 are a cause of hereditary pyropoikilocytosis (HPP). HPP is an autosomal recessive disorder characterized by hemolytic anemia, microspherocytosis, poikilocytosis, and an unusual thermal sensitivity of red cells. Defects in SPTA1 are the cause of spherocytosis type 3 (SPH3); also known as hereditary spherocytosis type 3 (HS3). Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. SPH3 is characterized by severe hemolytic anemia. Inheritance is autosomal recessive. Belongs to the spectrin family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Cytoskeletal; Motility/polarity/chemotaxis
Chromosomal Location of Human Ortholog: 1q21
Cellular Component: spectrin; cytosol; actin cytoskeleton
Molecular Function: actin filament binding; protein binding; structural constituent of cytoskeleton; protein heterodimerization activity; calcium ion binding
Biological Process: axon guidance; regulation of cell shape; positive regulation of protein binding; plasma membrane organization and biogenesis; actin filament capping; actin filament organization; positive regulation of T cell proliferation; hemopoiesis; lymphocyte homeostasis; porphyrin biosynthetic process
Disease: Elliptocytosis 2; Pyropoikilocytosis, Hereditary; Spherocytosis, Type 3
Research Articles on SPTAN1
1. In this review, we summarize the state of knowledge about interactions between spectrin and membrane lipids
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.